Potential interventions for novel coronavirus in China: A systematic review.
Identifieur interne : 000391 ( Main/Exploration ); précédent : 000390; suivant : 000392Potential interventions for novel coronavirus in China: A systematic review.
Auteurs : Lei Zhang [République populaire de Chine] ; Yunhui Liu [République populaire de Chine]Source :
- Journal of medical virology [ 1096-9071 ] ; 2020.
Descripteurs français
- KwdFr :
- Antiviraux (usage thérapeutique), Chine, Facteurs immunologiques (usage thérapeutique), Humains, Immunisation passive, Infections à coronavirus (), Infections à coronavirus (traitement médicamenteux), Oligoéléments (usage thérapeutique), Plasma sanguin, Pneumopathie virale (), Vaccins antiviraux (administration et posologie), Vitamines (usage thérapeutique), État nutritionnel.
- MESH :
- administration et posologie : Vaccins antiviraux.
- traitement médicamenteux : Infections à coronavirus.
- usage thérapeutique : Antiviraux, Facteurs immunologiques, Oligoéléments, Vitamines.
- Chine, Humains, Immunisation passive, Infections à coronavirus, Plasma sanguin, Pneumopathie virale, État nutritionnel.
- Wicri :
- geographic : République populaire de Chine.
English descriptors
- KwdEn :
- Antiviral Agents (therapeutic use), Betacoronavirus (immunology), Betacoronavirus (pathogenicity), China, Coronavirus Infections (drug therapy), Coronavirus Infections (prevention & control), Coronavirus Infections (therapy), Humans, Immunization, Passive, Immunologic Factors (therapeutic use), Nutritional Status, Plasma, Pneumonia, Viral (therapy), Trace Elements (therapeutic use), Viral Vaccines (administration & dosage), Vitamins (therapeutic use).
- MESH :
- chemical , administration & dosage : Viral Vaccines.
- chemical , therapeutic use : Antiviral Agents, Immunologic Factors, Trace Elements, Vitamins.
- geographic : China.
- drug therapy : Coronavirus Infections.
- immunology : Betacoronavirus.
- pathogenicity : Betacoronavirus.
- prevention & control : Coronavirus Infections.
- therapy : Coronavirus Infections, Pneumonia, Viral.
- Humans, Immunization, Passive, Nutritional Status, Plasma.
Abstract
An outbreak of a novel coronavirus (COVID-19 or 2019-CoV) infection has posed significant threats to international health and the economy. In the absence of treatment for this virus, there is an urgent need to find alternative methods to control the spread of disease. Here, we have conducted an online search for all treatment options related to coronavirus infections as well as some RNA-virus infection and we have found that general treatments, coronavirus-specific treatments, and antiviral treatments should be useful in fighting COVID-19. We suggest that the nutritional status of each infected patient should be evaluated before the administration of general treatments and the current children's RNA-virus vaccines including influenza vaccine should be immunized for uninfected people and health care workers. In addition, convalescent plasma should be given to COVID-19 patients if it is available. In conclusion, we suggest that all the potential interventions be implemented to control the emerging COVID-19 if the infection is uncontrollable.
DOI: 10.1002/jmv.25707
PubMed: 32052466
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000802
- to stream PubMed, to step Curation: 000802
- to stream PubMed, to step Checkpoint: 000319
- to stream Ncbi, to step Merge: 003171
- to stream Ncbi, to step Curation: 003171
- to stream Ncbi, to step Checkpoint: 003171
- to stream Main, to step Merge: 000391
- to stream Main, to step Curation: 000391
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Potential interventions for novel coronavirus in China: A systematic review.</title><author><name sortKey="Zhang, Lei" sort="Zhang, Lei" uniqKey="Zhang L" first="Lei" last="Zhang">Lei Zhang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning</wicri:regionArea><wicri:noRegion>Liaoning</wicri:noRegion></affiliation></author><author><name sortKey="Liu, Yunhui" sort="Liu, Yunhui" uniqKey="Liu Y" first="Yunhui" last="Liu">Yunhui Liu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning</wicri:regionArea><wicri:noRegion>Liaoning</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32052466</idno><idno type="pmid">32052466</idno><idno type="doi">10.1002/jmv.25707</idno><idno type="wicri:Area/PubMed/Corpus">000802</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000802</idno><idno type="wicri:Area/PubMed/Curation">000802</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000802</idno><idno type="wicri:Area/PubMed/Checkpoint">000319</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000319</idno><idno type="wicri:Area/Ncbi/Merge">003171</idno><idno type="wicri:Area/Ncbi/Curation">003171</idno><idno type="wicri:Area/Ncbi/Checkpoint">003171</idno><idno type="wicri:Area/Main/Merge">000391</idno><idno type="wicri:Area/Main/Curation">000391</idno><idno type="wicri:Area/Main/Exploration">000391</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Potential interventions for novel coronavirus in China: A systematic review.</title><author><name sortKey="Zhang, Lei" sort="Zhang, Lei" uniqKey="Zhang L" first="Lei" last="Zhang">Lei Zhang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning</wicri:regionArea><wicri:noRegion>Liaoning</wicri:noRegion></affiliation></author><author><name sortKey="Liu, Yunhui" sort="Liu, Yunhui" uniqKey="Liu Y" first="Yunhui" last="Liu">Yunhui Liu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning</wicri:regionArea><wicri:noRegion>Liaoning</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of medical virology</title><idno type="eISSN">1096-9071</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term><term>Betacoronavirus (immunology)</term><term>Betacoronavirus (pathogenicity)</term><term>China</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (therapy)</term><term>Humans</term><term>Immunization, Passive</term><term>Immunologic Factors (therapeutic use)</term><term>Nutritional Status</term><term>Plasma</term><term>Pneumonia, Viral (therapy)</term><term>Trace Elements (therapeutic use)</term><term>Viral Vaccines (administration & dosage)</term><term>Vitamins (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (usage thérapeutique)</term><term>Chine</term><term>Facteurs immunologiques (usage thérapeutique)</term><term>Humains</term><term>Immunisation passive</term><term>Infections à coronavirus ()</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Oligoéléments (usage thérapeutique)</term><term>Plasma sanguin</term><term>Pneumopathie virale ()</term><term>Vaccins antiviraux (administration et posologie)</term><term>Vitamines (usage thérapeutique)</term><term>État nutritionnel</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term><term>Immunologic Factors</term><term>Trace Elements</term><term>Vitamins</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antiviraux</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term><term>Facteurs immunologiques</term><term>Oligoéléments</term><term>Vitamines</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Immunization, Passive</term><term>Nutritional Status</term><term>Plasma</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Chine</term><term>Humains</term><term>Immunisation passive</term><term>Infections à coronavirus</term><term>Plasma sanguin</term><term>Pneumopathie virale</term><term>État nutritionnel</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">An outbreak of a novel coronavirus (COVID-19 or 2019-CoV) infection has posed significant threats to international health and the economy. In the absence of treatment for this virus, there is an urgent need to find alternative methods to control the spread of disease. Here, we have conducted an online search for all treatment options related to coronavirus infections as well as some RNA-virus infection and we have found that general treatments, coronavirus-specific treatments, and antiviral treatments should be useful in fighting COVID-19. We suggest that the nutritional status of each infected patient should be evaluated before the administration of general treatments and the current children's RNA-virus vaccines including influenza vaccine should be immunized for uninfected people and health care workers. In addition, convalescent plasma should be given to COVID-19 patients if it is available. In conclusion, we suggest that all the potential interventions be implemented to control the emerging COVID-19 if the infection is uncontrollable.</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Zhang, Lei" sort="Zhang, Lei" uniqKey="Zhang L" first="Lei" last="Zhang">Lei Zhang</name></noRegion><name sortKey="Liu, Yunhui" sort="Liu, Yunhui" uniqKey="Liu Y" first="Yunhui" last="Liu">Yunhui Liu</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000391 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000391 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32052466
|texte= Potential interventions for novel coronavirus in China: A systematic review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32052466" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |